EIF2AK1 Antikörper (AA 388-630)
Kurzübersicht für EIF2AK1 Antikörper (AA 388-630) (ABIN7569195)
Target
Alle EIF2AK1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 388-630
-
Verwendungszweck
- Anti-Human EIF2AK1 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human EIF2AK1 (Glu388-Gly630).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
-
Andere Bezeichnung
- EIF2AK1
-
Hintergrund
- Eukaryotic translation initiation factor 2-alpha kinase 1, EIF2AK1, Hemin-sensitive initiation factor 2-alpha kinase, Heme-regulated inhibitor, HRI, Heme-controlled repressor, KIAA1369, Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase, hHRI, HCR
-
UniProt
- Q9BQI3
-
Pathways
- Hepatitis C
Target
-